Castleark Management LLC Sarepta Therapeutics, Inc. Transaction History

Castleark Management LLC

$2.41 Billion
Q2 2024

A detailed history of Castleark Management LLC transactions in Sarepta Therapeutics, Inc. stock. As of the latest transaction made, Castleark Management LLC holds 3,740 shares of SRPT stock, worth $450,445. This represents 0.02% of its overall portfolio holdings.

Number of Shares

3,740

Previous 2,350 59.15%

Holding current value

$450,445

Previous $304,000 94.08%

% of portfolio

0.02%

Previous 0.01%

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 13, 2024	BUY	$113.33 - $163.85 $157,528 - $227,751	1,390 Added 59.15%	3,740 $590,000
Q1 2024 May 15, 2024	BUY	$93.7 - $141.53 $220,195 - $332,595	2,350 New	2,350 $304,000
Q4 2022 Feb 09, 2023	SELL	$100.86 - $132.13 $961,195 - $1.26 Million	-9,530 Reduced 18.7%	41,440 $5.37 Million
Q3 2022 Nov 15, 2022	BUY	$75.71 - $119.24 $3.86 Million - $6.08 Million	50,970 New	50,970 $5.63 Million
Q1 2021 May 14, 2021	SELL	$72.25 - $168.95 $574,026 - $1.34 Million	-7,945 Closed	0 $0
Q4 2020 Feb 17, 2021	SELL	$125.56 - $178.74 $102,331 - $145,673	-815 Reduced 9.3%	7,945 $1.36 Million
Q3 2020 Nov 16, 2020	BUY	$127.12 - $172.34 $387,716 - $525,637	3,050 Added 53.42%	8,760 $1.23 Million
Q2 2020 Aug 14, 2020	BUY	$93.0 - $171.7 $531,030 - $980,406	5,710 New	5,710 $916,000
Q2 2019 Aug 13, 2019	SELL	$112.21 - $151.95 $1.26 Million - $1.7 Million	-11,210 Closed	0 $0
Q1 2019 May 14, 2019	SELL	$106.67 - $151.68 $23,467 - $33,369	-220 Reduced 1.92%	11,210 $1.34 Million
Q4 2018 Feb 12, 2019	SELL	$97.32 - $148.76 $6.8 Million - $10.4 Million	-69,875 Reduced 85.94%	11,430 $1.25 Million
Q3 2018 Nov 15, 2018	BUY	$115.31 - $161.51 $1.36 Million - $1.91 Million	11,835 Added 17.04%	81,305 $13.1 Million
Q2 2018 Aug 15, 2018	SELL	$71.74 - $153.69 $2.42 Million - $5.18 Million	-33,708 Reduced 32.67%	69,470 $9.18 Million
Q1 2018 May 15, 2018	SELL	$54.02 - $82.27 $9.7 Million - $14.8 Million	-179,632 Reduced 63.52%	103,178 $7.64 Million
Q4 2017 Feb 15, 2018	SELL	$47.64 - $56.75 $58,120 - $69,235	-1,220 Reduced 0.43%	282,810 $15.7 Million
Q3 2017 Nov 15, 2017	BUY	$35.73 - $47.15 $10.1 Million - $13.4 Million	284,030	284,030 $12.9 Million

Others Institutions Holding SRPT

# of Institutions

559

Shares Held

85.5M

Call Options Held

3.67M

Put Options Held

1.75M

View Full List

About Sarepta Therapeutics, Inc.

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $10.5B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

More about SRPT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Castleark Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Castleark Management LLC with notifications on news.

Account

Castleark Management LLC Sarepta Therapeutics, Inc. Transaction History